Literature DB >> 22133060

Influence of Emblica officinalis aqueous extract on growth and antioxidant defense system of human hepatoma cell line (HepG2).

Mahesh Mysore Shivananjappa1, Manoj Kumar Joshi.   

Abstract

CONTEXT: Amla [Emblica officinalis Gaertn. (Euphorbiaceae)], a major constituent of several herbal formulations, is a well-known hepatoprotectant. Despite its extensive use, mechanistic understanding of its antioxidant action is rather limited.
OBJECTIVE: In the current study, we investigated the effects of E. officinalis extracts (from dried fruits) on cellular oxidative state using a hepatocyte cell line (HepG2). We hypothesize that E. officinalis aqueous extracts have potency to modulate basal oxidative markers and enhance endogenous antioxidant defenses.
MATERIALS AND METHODS: Cells were incubated with aqueous extracts of E. officinalis (1-100 μg/ml) for varied time points (4-24 h) and biochemical markers of oxidative stress were determined in cell lysate. DISCUSSION: Aqueous extracts of E. officinalis at 100 μg/ml can significantly modulate the basal levels of oxidative markers and enhance antioxidant defenses of the cells.
CONCLUSIONS: Our findings clearly indicate the propensity of E. officinalis aqueous extracts to improve endogenous antioxidant defenses in HepG2 cells. Although further studies are required to assess their efficacy under experimentally induced oxidative, our data suggest that the hepatoprotective effects of E. officinalis reported earlier may be largely due to its potential to enhance the antioxidant defenses in vivo.
RESULTS: Because E. officinalis up to 100 μg/ml concentrations had no effect on cell viability; it was considered noncytotoxic. Incubation with E. officinalis for 24 h resulted in significant diminution in the levels of lipid hydroperoxide (18-42%) and reactive oxygen species (11-29%). Furthermore; E. officinalis increased the levels of glutathione (GSH; 18-32%); antioxidant capacity (19-31%); and activities of antioxidant enzymes (superoxide dismutase; 25-41%; catalase; 39-50%; GSH peroxidase; 20-35%; GSH reductase; 26-35%; and GSH S-transferase; 12-30%).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22133060     DOI: 10.3109/13880209.2011.618501

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  4 in total

Review 1.  Molecular Mechanisms of Cancer Prevention by Gooseberry (Phyllanthus emblica).

Authors:  Gaurav Kumar; Venkateshwar Madka; Gopal Pathuri; Vishal Ganta; Chinthalapally V Rao
Journal:  Nutr Cancer       Date:  2021-11-28       Impact factor: 2.816

Review 2.  Functional and Nutraceutical Significance of Amla (Phyllanthus emblica L.): A Review.

Authors:  Maryam Gul; Zhi-Wei Liu; Roshina Rabail; Fatima Faheem; Noman Walayat; Asad Nawaz; Muhammad Asim Shabbir; Paulo E S Munekata; José M Lorenzo; Rana Muhammad Aadil
Journal:  Antioxidants (Basel)       Date:  2022-04-22

Review 3.  Anticancer Properties of Phyllanthus emblica (Indian Gooseberry).

Authors:  Tiejun Zhao; Qiang Sun; Maud Marques; Michael Witcher
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

4.  Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study.

Authors:  Mahendra Parkash Kapoor; Koji Suzuki; Timm Derek; Makoto Ozeki; Tsutomu Okubo
Journal:  Contemp Clin Trials Commun       Date:  2019-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.